Recombinant Human AEN Protein ，His & SUMO

AEN (Aminoacyl-tRNA Editing Nuclease) is a crucial protein associated with the fidelity of protein synthesis in cells, specifically in the context of tRNA editing. The research surrounding AEN has gained traction due to its pivotal role in preventing errors during aminoacylation, where tRNA molecules are charged with their corresponding amino acids. Misacylation can lead to the incorporation of incorrect amino acids into proteins, resulting in malfunctioning enzymes and altered cellular functions. The study of AEN is particularly relevant as it offers insights into the mechanisms of translation accuracy and its implications in various diseases, including cancer and genetic disorders. Recent advances have elucidated the structure-function relationships of AEN, revealing its catalytic properties and interactions with tRNA substrates. These findings pave the way for potential therapeutic applications, such as developing drugs that target the AEN pathway to enhance or inhibit its function, thereby providing a novel approach to rectify translation errors that contribute to disease pathology. Understanding the recombinant expression of AEN and the characterization of its activity can also facilitate the development of biotechnological applications, including the engineering of more accurate protein synthesis systems. Overall, the ongoing research into AEN is crucial not only for fundamental biology but also for its potential applications in medicine and biotechnology.